Draft Commission Implementing Decision on the non-approval of 1,3- Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) as an existing active substance for use in biocidal products of product types 6 and 13in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council; (4 page(s), in English)

Partial Amendment of the Act on the Safety of Regenerative Medicine; (1 page(s), in English)

Amendment to the Enforcement Order of Industrial Safety and Health Act and related ordinances about the substances subject to labelling and notice; (1 page(s), in English), (15 page(s), in English), (17 page(s), in English)